Hanmi and HHP will grant Gilead an exclusive license to Encequidar and provide access to drug supply. SEOUL, South Korea, Sept. 29, 2025 /PRNewswire/ -- Hanmi Pharm announced on September 29 that it has entered into a global licensing and collaboration agreement with Gilead Sciences, Inc....
Hence then, the article about hanmi s oral delivery platform compound licensed to gilead was published today ( ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.
Read More Details
Finally We wish PressBee provided you with enough information of ( Hanmi's Oral Delivery Platform Compound Licensed to Gilead )
Also on site :
- Lola Tung and Daniel Bravo Hernández to Lead New York Theatre Workshop Benefit Reading of ‘Sanctuary City’
- 1987 MTV Music Video, Produced by The Monkees’ Mike Nesmith, Helped Bring Iconic Michael Jackson Song to No. 1
- PepsiCo Teases a Major Rebrand—Here’s What’s Actually Happening